• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腰椎穿刺给予白藜芦醇可抑制信号转导和转录激活因子3(STAT3)的激活,增强原位大鼠胶质母细胞瘤中的自噬和凋亡。

Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.

作者信息

Xue Song, Xiao-Hong Shu, Lin Sha, Jie Bian, Li-Li Wang, Jia-Yao Gu, Shun Shi, Pei-Nan Li, Mo-Li Wu, Qian Wang, Xiao-Yan Chen, Qing-You Kong, Peng Zhang, Hong Li, Jia Liu

机构信息

Liaoning Laboratory of Cancer Genomics and Department of Cell Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.

Department of Radiology, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.

出版信息

Oncotarget. 2016 Nov 15;7(46):75790-75799. doi: 10.18632/oncotarget.12414.

DOI:10.18632/oncotarget.12414
PMID:27716625
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5342778/
Abstract

Trans-resveratrol suppresses glioblastoma growth in vitro, but its effects on intracranial glioblastomas remain untested. Resveratrol crosses the blood-brain barrier, and lumbar puncture (LP) greatly increases its bioavailability in rat brains; therefore, we investigated the effectiveness of LP-administered resveratrol on orthotopic rat glioblastomas. Twenty-four tumor-bearing rats were separated into two groups: Group 1 receiving 100 μl saline containing 0.3% DMSO and Group 2 receiving 100 μl resveratrol (300 μM). Treatments started 3 days after transplantation in 2-day intervals until death. Intracranial drug availabilities, tumor sizes, average life spans and the impacts on STAT3 signaling, apoptosis and autophagy rates were evaluated. MRI imaging revealed that average tumor size in the LP group (495.8 ± 22.3 mm2) was smaller than the control groups (810.3 ± 56.4 mm2; P<0.05). The mean survival time in the LP group (22.2 ± 2.1 d) was longer than control animals (16.0 ± 1.8 d; P<0.05). LP resveratrol-treated glioblastomas showed less Cyclin D1 staining, enhanced autophagy with up-regulated LC3 and Beclin1 expression, and widely distributed apoptotic foci around tumor capillaries with suppressed STAT3 expression and nuclear translocation. In conclusion, LP-delivered resveratrol efficiently inhibited orthotopic rat glioblastoma growth by inactivating STAT3 signaling and enhancing autophagy and apoptosis.

摘要

反式白藜芦醇在体外可抑制胶质母细胞瘤的生长,但其对颅内胶质母细胞瘤的影响尚未得到验证。白藜芦醇可穿过血脑屏障,腰椎穿刺(LP)可显著提高其在大鼠脑中的生物利用度;因此,我们研究了经LP给予白藜芦醇对原位大鼠胶质母细胞瘤的疗效。将24只荷瘤大鼠分为两组:第1组接受含0.3%DMSO的100μl生理盐水,第2组接受100μl白藜芦醇(300μM)。移植后3天开始治疗,每隔2天进行一次,直至死亡。评估颅内药物可及性、肿瘤大小、平均寿命以及对STAT3信号传导、凋亡和自噬率的影响。MRI成像显示,LP组的平均肿瘤大小(495.8±22.3mm2)小于对照组(810.3±56.4mm2;P<0.05)。LP组的平均生存时间(22.2±2.1天)长于对照动物(16.0±1.8天;P<0.05)。经LP白藜芦醇治疗的胶质母细胞瘤显示细胞周期蛋白D1染色减少,自噬增强,LC3和Beclin1表达上调,肿瘤毛细血管周围凋亡灶广泛分布,STAT3表达和核转位受到抑制。总之,经LP给予的白藜芦醇通过使STAT3信号失活并增强自噬和凋亡,有效抑制了原位大鼠胶质母细胞瘤的生长。

相似文献

1
Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas.腰椎穿刺给予白藜芦醇可抑制信号转导和转录激活因子3(STAT3)的激活,增强原位大鼠胶质母细胞瘤中的自噬和凋亡。
Oncotarget. 2016 Nov 15;7(46):75790-75799. doi: 10.18632/oncotarget.12414.
2
Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.术后白藜芦醇给药可改善大鼠原位脑胶质瘤的预后。
BMC Cancer. 2018 Sep 3;18(1):871. doi: 10.1186/s12885-018-4771-1.
3
Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.Notch-1 激活依赖性 p53 恢复有助于白藜芦醇诱导脑胶质瘤细胞凋亡。
Oncol Rep. 2011 Oct;26(4):925-30. doi: 10.3892/or.2011.1380. Epub 2011 Jul 4.
4
PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.PIAS3、SHP2和SOCS3在宫颈癌中的表达模式:与STAT3信号通路的激活及白藜芦醇诱导的失活的相关性
Gynecol Oncol. 2015 Dec;139(3):529-35. doi: 10.1016/j.ygyno.2015.09.087. Epub 2015 Oct 4.
5
Resveratrol inhibits phosphorylation within the signal transduction and activator of transcription 3 signaling pathway by activating sirtuin 1 in SW1353 chondrosarcoma cells.白藜芦醇通过激活SW1353软骨肉瘤细胞中的沉默调节蛋白1,抑制信号转导和转录激活因子3信号通路中的磷酸化作用。
Mol Med Rep. 2016 Sep;14(3):2685-90. doi: 10.3892/mmr.2016.5554. Epub 2016 Jul 27.
6
Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.白藜芦醇在人神经胶质瘤细胞中的代谢模式和生物转化活性:与治疗效果的相关性。
PLoS One. 2011;6(11):e27484. doi: 10.1371/journal.pone.0027484. Epub 2011 Nov 11.
7
Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications.白藜芦醇经不同途径给药至大鼠脑的扩散效率和生物利用度:治疗意义
Neurotherapeutics. 2015 Apr;12(2):491-501. doi: 10.1007/s13311-014-0334-6.
8
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.白藜芦醇抑制体内小鼠模型中的卵巢肿瘤生长。
Cancer. 2016 Mar 1;122(5):722-9. doi: 10.1002/cncr.29793. Epub 2015 Nov 30.
9
Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.评估白藜芦醇在人及大鼠脑胶质瘤细胞中的敏感性和代谢模式。
Cancer Chemother Pharmacol. 2013 Nov;72(5):965-73. doi: 10.1007/s00280-013-2274-y. Epub 2013 Aug 30.
10
Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells.抑制STAT3信号传导作为白藜芦醇抑制卵巢癌细胞的关键分子事件。
J Ovarian Res. 2015 Apr 22;8:25. doi: 10.1186/s13048-015-0152-4.

引用本文的文献

1
Potential Therapeutic Efficacy of Ferulic Acid and Its Derivatives in the Management of Cancers: A Comprehensive Analysis With Mechanistic Insight.阿魏酸及其衍生物在癌症治疗中的潜在疗效:基于机制洞察的综合分析
Int J Food Sci. 2025 May 30;2025:2256871. doi: 10.1155/ijfo/2256871. eCollection 2025.
2
Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms.天然产物在治疗神经胶质瘤中的潜力:聚焦于分子机制。
Cell Biochem Biophys. 2024 Dec;82(4):3157-3208. doi: 10.1007/s12013-024-01447-x. Epub 2024 Aug 16.
3
Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.

本文引用的文献

1
Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery.高场强术中磁共振成像对小儿低级别胶质瘤手术疗效的有益影响。
Neurosurg Focus. 2016 Mar;40(3):E13. doi: 10.3171/2015.11.FOCUS15530.
2
Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.白藜芦醇的特性:关于动物模型和人类的代谢、生物利用度及生物学效应的体外和体内研究
Oxid Med Cell Longev. 2015;2015:837042. doi: 10.1155/2015/837042. Epub 2015 Jun 28.
3
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.
构建针对神经胶质瘤细胞的白介素-13 受体 α2 靶向性白藜芦醇纳米粒子:治疗效果和分子作用。
Int J Mol Sci. 2021 Sep 30;22(19):10622. doi: 10.3390/ijms221910622.
4
Influence of Ce Substitution on Antimicrobial and Antibiofilm Properties of ZnCeFeO Nanoparticles (X = 0.0, 0.02, 0.04, 0.06, and 0.08) Conjugated with Ebselen and Its Role Subsidised with γ-Radiation in Mitigating Human TNBC and Colorectal Adenocarcinoma Proliferation In Vitro.Ce 取代对与 Ebselen 结合的 ZnCeFeO 纳米粒子(X=0.0、0.02、0.04、0.06 和 0.08)的抗菌和抗生物膜性能的影响及其在减轻体外人三阴性乳腺癌和结直肠腺癌增殖中的 γ 辐射辅助作用。
Int J Mol Sci. 2021 Sep 21;22(18):10171. doi: 10.3390/ijms221810171.
5
The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?多面的 NF-κB:其抑制是否仍有用于儿科中枢神经系统肿瘤临床干预的前景?
Cell Mol Life Sci. 2021 Sep;78(17-18):6161-6200. doi: 10.1007/s00018-021-03906-7. Epub 2021 Jul 31.
6
Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review.白藜芦醇在胶质母细胞瘤治疗中联合放疗和化疗的治疗潜力:一项机制综述
Cancer Cell Int. 2021 Jul 21;21(1):391. doi: 10.1186/s12935-021-02099-0.
7
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma.JAK/STAT信号通路在胶质母细胞瘤中的作用及治疗靶点
Cancers (Basel). 2021 Jan 24;13(3):437. doi: 10.3390/cancers13030437.
8
Increased Reactive Oxygen Species and Distinct Oxidative Damage in Resveratrol-suppressed Glioblastoma Cells.白藜芦醇抑制的胶质母细胞瘤细胞中活性氧增加及明显的氧化损伤
J Cancer. 2021 Jan 1;12(1):141-149. doi: 10.7150/jca.45489. eCollection 2021.
9
Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications.白藜芦醇与替莫唑胺对胶质母细胞瘤细胞的协同作用:潜在机制与治疗意义
Cancer Manag Res. 2020 Sep 11;12:8341-8354. doi: 10.2147/CMAR.S258584. eCollection 2020.
10
Natural products and phytochemical nanoformulations targeting mitochondria in oncotherapy: an updated review on resveratrol.天然产物和植物化学纳米制剂靶向肿瘤治疗中的线粒体:白藜芦醇的最新综述。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200257.
恶性胶质瘤交变电场疗法的循证综述
Curr Treat Options Oncol. 2015 Aug;16(8):40. doi: 10.1007/s11864-015-0353-5.
4
Resveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling Pathway.白藜芦醇通过下调PI3K/Akt/NF-κB信号通路抑制胶质母细胞瘤起始细胞的侵袭
Nutrients. 2015 Jun 2;7(6):4383-402. doi: 10.3390/nu7064383.
5
The role of STAT3 in autophagy.信号转导和转录激活因子3(STAT3)在自噬中的作用。
Autophagy. 2015;11(5):729-39. doi: 10.1080/15548627.2015.1017192.
6
Clostridium novyi-NT can cause regression of orthotopically implanted glioblastomas in rats.诺维氏梭菌NT型可使大鼠原位植入的胶质母细胞瘤发生消退。
Oncotarget. 2015 Mar 20;6(8):5536-46. doi: 10.18632/oncotarget.3627.
7
FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.FoxM1驱动一个促进胶质母细胞瘤干细胞样细胞自我更新和致瘤性的前馈STAT3激活信号环。
Cancer Res. 2015 Jun 1;75(11):2337-48. doi: 10.1158/0008-5472.CAN-14-2800. Epub 2015 Apr 1.
8
The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.交变电场在胶质母细胞瘤中的作用:关于治疗机制和临床结果的当前证据。
Neurosurg Focus. 2015 Mar;38(3):E14. doi: 10.3171/2015.1.FOCUS14742.
9
Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.胶质母细胞瘤患者抗血管内皮生长因子及抗血管内皮生长因子受体试验的经验教训。
J Clin Oncol. 2015 Apr 1;33(10):1197-213. doi: 10.1200/JCO.2014.55.9575. Epub 2015 Feb 23.
10
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma.一项使用抗表皮生长因子受体单克隆抗体尼妥珠单抗治疗新诊断成人间变性星形细胞瘤的随机、开放标签III期试验。
Eur J Cancer. 2015 Mar;51(4):522-532. doi: 10.1016/j.ejca.2014.12.019. Epub 2015 Jan 20.